Evidence map›Paper›PMID 39198917›Full record

ArticleHuman genomics2024

Variant Impact Predictor database (VIPdb), version 2: trends from three decades of genetic variant impact predictors.

Yu-Jen Lin, Arul S Menon, Zhiqiang Hu, Steven E Brenner

Abstract read
In one paragraph

Article in Human genomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Calibration of additional computational tools expands ClinGen recommendation options for variant classification with PP3/BP4 criteria.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. PON-P3: Accurate Prediction of Pathogenicity of Amino Acid Substitutions.International journal of molecular sciences · 2025
    Article
  13. Article
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Yu-Jen Lin *Department of Molecular and Cell Biology, University of California, Berkeley, CA, 94720, USA.ORCID 0000-0002-0224-0281
Arul S Menon *Department of Molecular and Cell Biology, University of California, Berkeley, CA, 94720, USA.ORCID 0009-0008-7552-3195
Zhiqiang HuDepartment of Plant and Microbial Biology, University of California, 111 Koshland Hall #3102, Berkeley, CA, 94720-3102, USA.ORCID 0000-0001-8854-3410
Steven E BrennerDepartment of Molecular and Cell Biology, University of California, Berkeley, CA, 94720, USA. brenner@compbio.berkeley.edu.ORCID 0000-0001-7559-6185

Funding

Center for Critical Assessment of Genome InterpretationU24HG007346 · NHGRI · UNIVERSITY OF CALIFORNIA BERKELEY · PI BRENNER, STEVEN E, IOANNIDIS, NILAH MONNIER · 2020 to 2025
$3.8M
NHGRI NIH HHS U24 HG007346NIH HHS U24 HG007346
6 · The paper itself

Abstract

backgroundVariant interpretation is essential for identifying patients' disease-causing genetic variants amongst the millions detected in their genomes. Hundreds of Variant Impact Predictors (VIPs), also known as Variant Effect Predictors (VEPs), have been developed for this purpose, with a variety of methodologies and goals. To facilitate the exploration of available VIP options, we have created the Variant Impact Predictor database (VIPdb).

resultsThe Variant Impact Predictor database (VIPdb) version 2 presents a collection of VIPs developed over the past three decades, summarizing their characteristics, ClinGen calibrated scores, CAGI assessment results, publication details, access information, and citation patterns. We previously summarized 217 VIPs and their features in VIPdb in 2019. Building upon this foundation, we identified and categorized an additional 190 VIPs, resulting in a total of 407 VIPs in VIPdb version 2. The majority of the VIPs have the capacity to predict the impacts of single nucleotide variants and nonsynonymous variants. More VIPs tailored to predict the impacts of insertions and deletions have been developed since the 2010s. In contrast, relatively few VIPs are dedicated to the prediction of splicing, structural, synonymous, and regulatory variants. The increasing rate of citations to VIPs reflects the ongoing growth in their use, and the evolving trends in citations reveal development in the field and individual methods.

conclusionsVIPdb version 2 summarizes 407 VIPs and their features, potentially facilitating VIP exploration for various variant interpretation applications. VIPdb is available at  https://genomeinterpretation.org/vipdb.

Indexed as

Databases, GeneticGenetic VariationComputational BiologyGenome, HumanGenomicsHumansPolymorphism, Single NucleotideSoftwareGenomic variantGenotype–phenotype relationshipIndelSNVSVVariant Effect Predictor (VEP)Variant Impact Predictor (VIP)Variant interpretationVIPdb

Identifiers

PMID39198917
PMCPMC11360829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.